Sign in to view content

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

Peter A. Campochiaro, MD

Video
Published 2020

Related

Chronical Submacular Hemorrhage in the Setting of Neovascular AMD
Rita Couceiro, MD, MS
carlos marques-neves, MD, PhD, EBO
Retina Image Bank: Images of the Week
2015
Wet AMD 7 Symposium
Annual Meeting Talks
2020
Retinal Physician Practice Patterns in the Setting of Anticoagulation
Allen Chiang, MD, FASRS
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more